InvestorsHub Logo
Followers 93
Posts 21466
Boards Moderated 0
Alias Born 06/07/2011

Re: Garden Rose post# 1550

Wednesday, 05/12/2021 3:33:26 PM

Wednesday, May 12, 2021 3:33:26 PM

Post# of 23069
I checked the JAMA site your listed, and all the studies are outdated from last year. Reported in 2021 but outdated since news trials confirm efficacy of hydroxy.

The conclusion as reported in 2021 are not outdated. The virus or disease pathology has not changed- outside of new more dangerous variants. HCQ still has the same molecular formula.

since news trials confirm efficacy of hydroxy.



List a few published in a reputable science journal such as NEJM, or JAMA.


Also, your last study had to do w/hospital patients. Hydroxy is not used for those hospitalized, it is for early onset patients.


Wrong. The Brazilian trial hydroxychloroquine or lopinavir-ritonavir was used as outpatient with those having mild disease.

Anutter trial concludes

Hydroxychloroquine did not substantially reduce symptom severity in outpatients with early, mild COVID-19.



Note the words "outpatient", "early",and "mild".

Now why don't you provide a few references from scientific journals. Because I can keep pulling up articles concluding HCQ doesn't do anything ... one article after another.

BTW - are you prepared to tell us how on the molecular level the mRNA vaccines are dangerous? Maybe it's the sucrose stabilizer in the Pfizer vaccine? LOL

The Jewel of the Mind is Colored with the Hue of what it Imagines

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.